The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 30, 2021
Filed:
Nov. 14, 2019
Applicant:
Delta-fly Pharma, Inc., Tokushima, JP;
Inventor:
Hiromi Wada, Kyoto, JP;
Assignee:
DELTA-FLY PHARMA, INC., Tokushima, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 9/00 (2006.01); A61P 35/02 (2006.01); A61K 31/506 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/165 (2013.01); A61K 9/0053 (2013.01); A61K 31/506 (2013.01); A61P 35/02 (2018.01); A61P 43/00 (2018.01);
Abstract
The present application provides a pharmaceutical composition for use in treatment or remission of patients with chronic myelogenous leukemia, wherein the composition comprises, as active ingredients, (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof, and 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide or a pharmacologically acceptable salt thereof, both of which are used at low doses.